NCL joins hands with BSV for industry-academia collaboration – Punekar News

June 13, 2022, Mumbai: With the endeavor to promote a research-driven ecosystem in the country, Bharat Serums and Vaccines Ltd. (BSV), a leading biopharmaceutical company in India, reiterates its commitment towards fundamental research through a partnership with the National Chemical Laboratory (NCL), Pune, a constituent laboratory of Council of Scientific and Industrial Research (CSIR), Government of India. This collaboration primarily focuses on evaluation of certain recombinant cell line technologies developed by NCL for biopharmaceutical products currently under development at BSV. The technology involves using CRISPR/Cas9 techniques to perform specific modifications of mammalian cell lines to achieve certain desired product quality attributes.




Speaking about this, Sanjiv Navangul, Managing Director & CEO, BSV said, “Research remains the DNA of everything we do. NCL has an outstanding track record of research involving partnerships with industry from concept to commercialization. Through this collaboration, we are delighted to tap some of the best research minds in the country in order to help us bring innovative treatments and cures for patients in…


Leave a Reply

Your email address will not be published.